Adewole Adamson, MD, MPP

Assistant Professor

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Adewole Adamson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Dermatology Medicine & Life Sciences
Medicare Medicine & Life Sciences
Skin Neoplasms Medicine & Life Sciences
Dysplastic Nevus Syndrome Medicine & Life Sciences
Medicare Part D Medicine & Life Sciences
T-Lymphocyte Subsets Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Prescriptions Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018: A Systematic Review

Pournamdari, A. B., Tkachenko, E., Barbieri, J., Adamson, A. S. & Mostaghimi, A., Dec 2019, In : JAMA Dermatology. 155, 12, p. 1410-1415 6 p.

Research output: Contribution to journalReview article

Dysplastic Nevus Syndrome
Sentinel Lymph Node Biopsy
Immunoglobulin Isotypes
Drug Delivery Systems
3 Citations (Scopus)

Eliminating Copayments for Skin Cancer Screening - A Public Health Policy with Insufficient Evidence

Adamson, A. S. & Pignone, M. P., Dec 2019, In : JAMA Dermatology. 155, 12, p. 1339-1340 2 p.

Research output: Contribution to journalComment/debate

Open Access
Skin Neoplasms
Public Policy
Health Policy
Early Detection of Cancer
Public Health

Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries

Singh, P., Forman, H., Adamson, A. S., Mostaghimi, A., Ogdie, A. R., Oganisian, A. & Barbieri, J. S., Feb 15 2019, In : Journal of general internal medicine. 34, 2, p. 176-178 3 p.

Research output: Contribution to journalComment/debate

Tumor Necrosis Factor-alpha
3 Citations (Scopus)

Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment

American Academy of Dermatology Association Task Force on Drug Pricing and Transparency, Feb 2019, In : Journal of the American Academy of Dermatology. 80, 2, p. 577-578 2 p.

Research output: Contribution to journalEditorial

United States Food and Drug Administration